United States Antibody Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Antibody Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Antibody Overall Market Size
2.1 United States Antibody Market Size: 2021 VS 2027
2.2 United States Antibody Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Antibody Sales: 2016-2027
3 Company Landscape
3.1 Top Antibody Players in United States Market
3.2 Top United States Antibody Companies Ranked by Revenue
3.3 United States Antibody Revenue by Companies
3.4 United States Antibody Sales by Companies
3.5 United States Antibody Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antibody Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody Players in United States Market
3.8.1 List of Tier 1 Antibody Companies in United States
3.8.2 List of Tier 2 and Tier 3 Antibody Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Antibody Market Size Markets, 2021 & 2027
4.1.2 IgM
4.1.3 IgG
4.1.4 IgA
4.1.5 Other
4.2 By Type - United States Antibody Revenue & Forecasts
4.2.1 By Type - United States Antibody Revenue, 2016-2021
4.2.2 By Type - United States Antibody Revenue, 2022-2027
4.2.3 By Type - United States Antibody Revenue Market Share, 2016-2027
4.3 By Type - United States Antibody Sales & Forecasts
4.3.1 By Type - United States Antibody Sales, 2016-2021
4.3.2 By Type - United States Antibody Sales, 2022-2027
4.3.3 By Type - United States Antibody Sales Market Share, 2016-2027
4.4 By Type - United States Antibody Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Antibody Market Size, 2021 & 2027
5.1.2 Therapeutic
5.1.3 Research
5.1.4 Diagnostic
5.2 By Application - United States Antibody Revenue & Forecasts
5.2.1 By Application - United States Antibody Revenue, 2016-2021
5.2.2 By Application - United States Antibody Revenue, 2022-2027
5.2.3 By Application - United States Antibody Revenue Market Share, 2016-2027
5.3 By Application - United States Antibody Sales & Forecasts
5.3.1 By Application - United States Antibody Sales, 2016-2021
5.3.2 By Application - United States Antibody Sales, 2022-2027
5.3.3 By Application - United States Antibody Sales Market Share, 2016-2027
5.4 By Application - United States Antibody Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Overview
6.1.3 Roche Antibody Sales and Revenue in United States Market (2016-2021)
6.1.4 Roche Antibody Product Description
6.1.5 Roche Recent Developments
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Overview
6.2.3 Johnson and Johnson Antibody Sales and Revenue in United States Market (2016-2021)
6.2.4 Johnson and Johnson Antibody Product Description
6.2.5 Johnson and Johnson Recent Developments
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Overview
6.3.3 Merck Antibody Sales and Revenue in United States Market (2016-2021)
6.3.4 Merck Antibody Product Description
6.3.5 Merck Recent Developments
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Overview
6.4.3 Novartis Antibody Sales and Revenue in United States Market (2016-2021)
6.4.4 Novartis Antibody Product Description
6.4.5 Novartis Recent Developments
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Overview
6.5.3 AbbVie Antibody Sales and Revenue in United States Market (2016-2021)
6.5.4 AbbVie Antibody Product Description
6.5.5 AbbVie Recent Developments
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Overview
6.6.3 Amgen Antibody Sales and Revenue in United States Market (2016-2021)
6.6.4 Amgen Antibody Product Description
6.6.5 Amgen Recent Developments
6.7 Pfizer
6.7.1 Pfizer Corporation Information
6.7.2 Pfizer Overview
6.7.3 Pfizer Antibody Sales and Revenue in United States Market (2016-2021)
6.7.4 Pfizer Antibody Product Description
6.7.5 Pfizer Recent Developments
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Overview
6.8.3 Bayer Antibody Sales and Revenue in United States Market (2016-2021)
6.8.4 Bayer Antibody Product Description
6.8.5 Bayer Recent Developments
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Overview
6.9.3 Lilly Antibody Sales and Revenue in United States Market (2016-2021)
6.9.4 Lilly Antibody Product Description
6.9.5 Lilly Recent Developments
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Overview
6.10.3 Bristol-Myers Squibb Antibody Sales and Revenue in United States Market (2016-2021)
6.10.4 Bristol-Myers Squibb Antibody Product Description
6.10.5 Bristol-Myers Squibb Recent Developments
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Overview
6.11.3 GlaxoSmithKline Antibody Sales and Revenue in United States Market (2016-2021)
6.11.4 GlaxoSmithKline Antibody Product Description
6.11.5 GlaxoSmithKline Recent Developments
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Overview
6.12.3 Biogen Antibody Sales and Revenue in United States Market (2016-2021)
6.12.4 Biogen Antibody Product Description
6.12.5 Biogen Recent Developments
6.13 AstraZeneca
6.13.1 AstraZeneca Corporation Information
6.13.2 AstraZeneca Overview
6.13.3 AstraZeneca Antibody Sales and Revenue in United States Market (2016-2021)
6.13.4 AstraZeneca Antibody Product Description
6.13.5 AstraZeneca Recent Developments
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Overview
6.14.3 Sanofi Antibody Sales and Revenue in United States Market (2016-2021)
6.14.4 Sanofi Antibody Product Description
6.14.5 Sanofi Recent Developments
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Corporation Information
6.15.2 Alexion Pharmaceuticals Overview
6.15.3 Alexion Pharmaceuticals Antibody Sales and Revenue in United States Market (2016-2021)
6.15.4 Alexion Pharmaceuticals Antibody Product Description
6.15.5 Alexion Pharmaceuticals Recent Developments
6.16 Seattle Genetics
6.16.1 Seattle Genetics Corporation Information
6.16.2 Seattle Genetics Overview
6.16.3 Seattle Genetics Antibody Sales and Revenue in United States Market (2016-2021)
6.16.4 Seattle Genetics Antibody Product Description
6.16.5 Seattle Genetics Recent Developments
7 United States Antibody Production Capacity, Analysis
7.1 United States Antibody Production Capacity, 2016-2027
7.2 Antibody Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Antibody Supply Chain Analysis
9.1 Antibody Industry Value Chain
9.2 Antibody Upstream Market
9.3 Antibody Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Antibody Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Antibody in United States Market
Table 2. Top Antibody Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Antibody Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Antibody Revenue Share by Companies, 2016-2021
Table 5. United States Antibody Sales by Companies, (KG), 2016-2021
Table 6. United States Antibody Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antibody Price (2016-2021) & (USD/KG)
Table 8. Manufacturers Antibody Product Type
Table 9. List of Tier 1 Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of IgM
Table 12. Major Manufacturers of IgG
Table 13. By Type - United States Antibody Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Antibody Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Antibody Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Antibody Sales (KG), 2016-2021
Table 17. By Type - United States Antibody Sales (KG), 2022-2027
Table 18. By Application - United States Antibody Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Antibody Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Antibody Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Antibody Sales (KG), 2016-2021
Table 22. By Application - United States Antibody Sales (KG), 2022-2027
Table 23. Roche Corporation Information
Table 24. Roche Description and Major Businesses
Table 25. Roche Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 26. Roche Antibody Product
Table 27. Roche Recent Developments
Table 28. Johnson and Johnson Corporation Information
Table 29. Johnson and Johnson Description and Major Businesses
Table 30. Johnson and Johnson Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 31. Johnson and Johnson Antibody Product
Table 32. Johnson and Johnson Recent Developments
Table 33. Merck Corporation Information
Table 34. Merck Description and Major Businesses
Table 35. Merck Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 36. Merck Antibody Product
Table 37. Merck Recent Developments
Table 38. Novartis Corporation Information
Table 39. Novartis Description and Major Businesses
Table 40. Novartis Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 41. Novartis Antibody Product
Table 42. Novartis Recent Developments
Table 43. AbbVie Corporation Information
Table 44. AbbVie Description and Major Businesses
Table 45. AbbVie Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 46. AbbVie Antibody Product
Table 47. AbbVie Recent Developments
Table 48. Amgen Corporation Information
Table 49. Amgen Description and Major Businesses
Table 50. Amgen Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 51. Amgen Antibody Product
Table 52. Amgen Recent Developments
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Major Businesses
Table 55. Pfizer Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 56. Pfizer Antibody Product
Table 57. Pfizer Recent Developments
Table 58. Bayer Corporation Information
Table 59. Bayer Description and Major Businesses
Table 60. Bayer Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 61. Bayer Antibody Product
Table 62. Bayer Recent Developments
Table 63. Lilly Corporation Information
Table 64. Lilly Description and Major Businesses
Table 65. Lilly Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 66. Lilly Antibody Product
Table 67. Lilly Recent Developments
Table 68. Bristol-Myers Squibb Corporation Information
Table 69. Bristol-Myers Squibb Description and Major Businesses
Table 70. Bristol-Myers Squibb Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 71. Bristol-Myers Squibb Antibody Product
Table 72. Bristol-Myers Squibb Recent Developments
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Major Businesses
Table 75. GlaxoSmithKline Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 76. GlaxoSmithKline Antibody Product
Table 77. GlaxoSmithKline Recent Developments
Table 78. Biogen Corporation Information
Table 79. Biogen Description and Major Businesses
Table 80. Biogen Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 81. Biogen Antibody Product
Table 82. Biogen Recent Developments
Table 83. AstraZeneca Corporation Information
Table 84. AstraZeneca Description and Major Businesses
Table 85. AstraZeneca Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 86. AstraZeneca Antibody Product
Table 87. AstraZeneca Recent Developments
Table 88. Sanofi Corporation Information
Table 89. Sanofi Description and Major Businesses
Table 90. Sanofi Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 91. Sanofi Antibody Product
Table 92. Sanofi Recent Developments
Table 93. Alexion Pharmaceuticals Corporation Information
Table 94. Alexion Pharmaceuticals Description and Major Businesses
Table 95. Alexion Pharmaceuticals Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 96. Alexion Pharmaceuticals Antibody Product
Table 97. Alexion Pharmaceuticals Recent Developments
Table 98. Seattle Genetics Corporation Information
Table 99. Seattle Genetics Description and Major Businesses
Table 100. Seattle Genetics Antibody Sales (KG), Revenue (US$, Mn) and Gross Margin (USD/KG) (2016-2021)
Table 101. Seattle Genetics Antibody Product
Table 102. Seattle Genetics Recent Developments
Table 103. Antibody Production Capacity (KG) of Key Manufacturers in United States Market, 2019-2021 (KG)
Table 104. United States Antibody Capacity Market Share of Key Manufacturers, 2019-2021
Table 105. Antibody Market Opportunities & Trends in United States Market
Table 106. Antibody Market Drivers in United States Market
Table 107. Antibody Market Restraints in United States Market
Table 108. Antibody Raw Materials
Table 109. Antibody Raw Materials Suppliers in United States Market
Table 110. Typical Antibody Downstream
Table 111. Antibody Downstream Clients in United States Market
Table 112. Antibody Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Antibody Product Picture
Figure 2. Antibody Segment by Type
Figure 3. Antibody Segment by Application
Figure 4. United States Antibody Market Overview: 2020
Figure 5. United States Antibody Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Antibody Revenue, 2016-2027 (US$, Mn)
Figure 7. Antibody Sales in United States Market: 2016-2027 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Antibody Revenue in 2020
Figure 9. IgM Product Picture
Figure 10. IgG Product Picture
Figure 11. IgA Product Picture
Figure 12. Other Product Picture
Figure 13. By Type - United States Antibody Sales Market Share, 2016-2027
Figure 14. By Type - United States Antibody Revenue Market Share, 2016-2027
Figure 15. By Type - United States Antibody Price (USD/KG), 2016-2027
Figure 16. Therapeutic
Figure 17. Research
Figure 18. Diagnostic
Figure 19. By Application - United States Antibody Sales Market Share, 2016-2027
Figure 20. By Application - United States Antibody Revenue Market Share, 2016-2027
Figure 21. By Application - United States Antibody Price (USD/KG), 2016-2027
Figure 22. Roche Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Johnson and Johnson Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Merck Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Novartis Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. AbbVie Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Amgen Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Pfizer Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Bayer Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Lilly Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Bristol-Myers Squibb Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. GlaxoSmithKline Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Biogen Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. AstraZeneca Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Sanofi Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Alexion Pharmaceuticals Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Seattle Genetics Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. United States Antibody Production Capacity (KG), 2016-2027
Figure 39. Antibody Industry Value Chain
Figure 40. Marketing Channels